Search research articles
Contact Us
Filters
Showing results (91-100 of 106) with videos related to
Page
of 11
Sort By:
Annals of Surgical Oncology
|
March 2, 2025
Correction: Preoperative MRI to Predict Upstaging of DCIS to Invasive Cancer at Surgery
Sara H Javid, Anum S Kazerouni, Daniel S Hippe, et al.
JAMA
|
February 26, 2020
Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening
Christopher E Comstock, Constantine Gatsonis, Gillian M Newstead, et al.
JAMA Oncology
|
October 16, 2025
Radiotherapy With a 12-Gene Expression Assay for Ductal Carcinoma In Situ: A Randomized Clinical Trial
Seema A Khan, Justin Romanoff, Constantine Gatsonis, et al.
JAMA Network Open
|
July 3, 2025
Quality of Life Among Patients With Ductal Carcinoma In Situ
Victoria J Dunsmore, Bradley S Snyder, Ilana F Gareen, et al.
JAMA Network Open
|
May 10, 2022
Association Between Surgery Preference and Receipt in Ductal Carcinoma In Situ After Breast Magnetic Resonance Imaging: An Ancillary Study of the ECOG-ACRIN Cancer Research Group (E4112)
Soudabeh Fazeli, Bradley S Snyder, Ilana F Gareen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2019
Utility of Diffusion-weighted Imaging to Decrease Unnecessary Biopsies Prompted by Breast MRI: A Trial of the ECOG-ACRIN Cancer Research Group (A6702)
Habib Rahbar, Zheng Zhang, Thomas L Chenevert, et al.
Radiology
|
April 29, 2025
Erratum for: MRI-based Radiomic Features for Risk Stratification of Ductal Carcinoma in Situ in a Multicenter Setting (ECOG-ACRIN E4112 Trial)
Kalina P Slavkova, Ruya Kang, Anum S Kazerouni, et al.
JAMA Oncology
|
January 18, 2019
Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay With Breast Ductal Carcinoma In Situ Treatment
Constance D Lehman, Constantine Gatsonis, Justin Romanoff, et al.
Radiology
|
April 1, 2025
MRI-based Radiomic Features for Risk Stratification of Ductal Carcinoma in Situ in a Multicenter Setting (ECOG-ACRIN E4112 Trial)
Kalina P Slavkova, Ruya Kang, Anum S Kazerouni, et al.
Radiology
|
August 3, 2021
Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial)
Shinn-Huey S Chou, Justin Romanoff, Constance D Lehman, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 106) with videos related to
Sort By:
Page
of 11
Annals of Surgical Oncology
|
March 2, 2025
Correction: Preoperative MRI to Predict Upstaging of DCIS to Invasive Cancer at Surgery
Sara H Javid, Anum S Kazerouni, Daniel S Hippe, et al.
JAMA
|
February 26, 2020
Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening
Christopher E Comstock, Constantine Gatsonis, Gillian M Newstead, et al.
JAMA Oncology
|
October 16, 2025
Radiotherapy With a 12-Gene Expression Assay for Ductal Carcinoma In Situ: A Randomized Clinical Trial
Seema A Khan, Justin Romanoff, Constantine Gatsonis, et al.
JAMA Network Open
|
July 3, 2025
Quality of Life Among Patients With Ductal Carcinoma In Situ
Victoria J Dunsmore, Bradley S Snyder, Ilana F Gareen, et al.
JAMA Network Open
|
May 10, 2022
Association Between Surgery Preference and Receipt in Ductal Carcinoma In Situ After Breast Magnetic Resonance Imaging: An Ancillary Study of the ECOG-ACRIN Cancer Research Group (E4112)
Soudabeh Fazeli, Bradley S Snyder, Ilana F Gareen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2019
Utility of Diffusion-weighted Imaging to Decrease Unnecessary Biopsies Prompted by Breast MRI: A Trial of the ECOG-ACRIN Cancer Research Group (A6702)
Habib Rahbar, Zheng Zhang, Thomas L Chenevert, et al.
Radiology
|
April 29, 2025
Erratum for: MRI-based Radiomic Features for Risk Stratification of Ductal Carcinoma in Situ in a Multicenter Setting (ECOG-ACRIN E4112 Trial)
Kalina P Slavkova, Ruya Kang, Anum S Kazerouni, et al.
JAMA Oncology
|
January 18, 2019
Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay With Breast Ductal Carcinoma In Situ Treatment
Constance D Lehman, Constantine Gatsonis, Justin Romanoff, et al.
Radiology
|
April 1, 2025
MRI-based Radiomic Features for Risk Stratification of Ductal Carcinoma in Situ in a Multicenter Setting (ECOG-ACRIN E4112 Trial)
Kalina P Slavkova, Ruya Kang, Anum S Kazerouni, et al.
Radiology
|
August 3, 2021
Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial)
Shinn-Huey S Chou, Justin Romanoff, Constance D Lehman, et al.
Page
of 11